 Approximately 18 subjects will be randomized to receive either a single dose of Treatment A standard target DMSO content theoretical 11.3 formulation of GSK1120212B or a single dose of Treatment B lower DMSO Content approximately 9.5 formulation of GSK1120212B followed by a 7 day incomplete wash-out period, then a single dose of the other treatment. 